La sindrome algodistrofica o Complex Regional Pain Syndrome type 1
Tóm tắt
Từ khóa
Tài liệu tham khảo
Merskey H, Bogduk N (eds) (1994) Classification of chronic pain syndromes and definition of terms. IASP press, Seattle
Harden RN, Bruehl S, Perez RS et al. (2010) Validation of proposed diagnostic criteria (the “Budapest criteria”) for complex regional pain syndrome. Pain 150:268–274
Marinus J, Moseley GL, Birklein F et al. (2011) Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol 10:637–648
Sandroni P, Benrud-Larson LM, McClelland RL, Low PA (2003) Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population based study. Pain 103:199–207
de Mos M, de Bruijn AG, Huygen FJ et al. (2007) The incidence of complex regional pain syndrome: a population-based study. Pain 129:12–20
Sabsovich I, Guo TZ, Wei T et al. (2008) TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I. Pain 137:507–519
Harden RN (2011) Cytokine imbalance/activity as a unifying hypothesis for the pathogenesis and pathophysiology of complex regional pain syndrome? Pain 152:247–248
Kingery WS (2010) Role of neuropeptide, cytokine, and growth factor signaling in complex regional pain syndrome. Pain Med 11:1239–1250
McCabe CS, Blake DR (2008) An embarrassment of pain perceptions? Toward an understanding of and explanation for the clinical presentation of CRPS type I. Rheumatology 47:1612–1616
de Tran QH, Duong S, Bertini P, Finlayson RJ (2010) Treatment of complex regional pain syndrome: a review of the evidence. Can J Anesth 57:149–166
Perez RS, Zollinger PE, Dijkstra PU et al. (2010) Evidence based guidelines for complex regional pain syndrome type 1. BMC Neurol 10:20
Cossins L, Okell RW, Cameron H et al. (2013) Treatment of complex regional pain syndrome in adults: a systematic review of randomized controlled trials published from June 2000 to February 2012. Eur J Pain 17:158–173
Kiralp MZ, Yildiz S, Vural D et al. (2004) Effectiveness of hyperbaric oxygen therapy in the treatment of complex regional pain syndrome. J Int Med Res 32:258–262
Fleisch H (1982) Bisphosphonates: mechanisms of action and clinical applications. In: Peck WA (ed) Bone and mineral research, Annual 1. Excerpta Medica, Amsterdam, pp 319–537
Cecchini MG, Fleisch H (1990) Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage. J Bone Miner Res 5:1019–1027
Moreau MF, Guillet C, Massin P et al. (2007) Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro. Biochem Pharmacol 73:718–723
Adami S, Fossaluzza V, Gatti D et al. (1997) Bisphosphonate therapy of reflex sympathetic dystrophy syndrome. Ann Rheum Dis 56:201–204
Manicourt DH, Brasseur JP, Boutsen Y et al. (2004) Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity. Arthritis Rheumatol 50:3690–3697
Robinson JN, Sandom J, Chapman PT (2004) Efficacy of pamidronate in complex regional pain syndrome type I. Pain Med 5:276–280
Breuer B, Pappagallo M, Ongseng F et al. (2008) An open-label pilot trial of ibandronate for complex regional pain syndrome. Clin J Pain 24:685–689
Varenna M, Zucchi F, Ghiringhelli D et al. (2000) Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study. J Rheumatol 27:1477–1483
Varenna M, Adami S, Rossini M et al. (2013) Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study. Rheumatology 52:534–542
Vande Berg BC, Lecouvet FE, Koutaissoff S et al. (2008) Bone marrow edema of the femoral head and transient osteoporosis of the hip. Eur J Radiol 67:68–77
Samdani A, Lachmann E, Nagler W (1998) Transient osteoporosis of the hip during pregnancy: a case report. Am J Phys Med Rehabil 77:153–156
La Montagna G, Malesci D, Tirri R, Valentini G (2005) Successful neridronate therapy in transient osteoporosis of the hip. Clin Rheumatol 24:67–69
Varenna M, Zucchi F, Binelli L et al. (2002) Intravenous pamidronate in the treatment of transient osteoporosis of the hip. Bone 31:96–101
Schapira D, Braun Moscovici Y, Gutierrez G, Nahir AM (2003) Severe transient osteoporosis of the hip during pregnancy. Successful treatment with intravenous biphosphonates. Clin Exp Rheumatol 21:107–110